Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking
Bladder Cancer, Cervical Cancer, Esophageal Cancer
About this trial
This is an interventional treatment trial for Bladder Cancer focused on measuring bladder cancer, cervical cancer, esophageal cancer, gastric cancer, renal cell carcinoma, adult primary liver cancer, non-small cell lung cancer, small cell lung cancer, pancreatic cancer, hypopharyngeal cancer, laryngeal cancer, lip and oral cavity cancer, nasopharyngeal cancer, oropharyngeal cancer, paranasal sinus and nasal cavity cancer, adult acute myeloid leukemia, tobacco use disorder
Eligibility Criteria
DISEASE CHARACTERISTICS:
African American who has smoked ≤ 10 cigarettes per day for ≥ 2 years AND has smoked for ≥ 25 days within the past month
- Not a heavy smoker
- No other forms of tobacco within the past 30 days
- Must be interested in stopping smoking
- No other smoker in the household enrolled in this study
PATIENT CHARACTERISTICS:
- Has a home address and a functioning telephone number
- Not planning to move from the Kansas City metro area within the next 12 months
- Not pregnant or nursing
- Negative pregnancy test
- No alcohol or substance abuse within the past year
- Not currently drinking ≥ 14 alcoholic drinks per week
- No binge drinking (5 or more drinks on one occasion) on at least two occasions within the past month
- No history of seizures or head trauma
- No history of bulimia or anorexia nervosa
- No myocardial infarction within the past 30 days
- No reported use of opiates, cocaine, or stimulants
- No diabetes requiring oral hypoglycemics or insulin
PRIOR CONCURRENT THERAPY:
- More than 30 days since prior nicotine replacement therapy, fluoxetine, clonidine, buspirone, or doxepin
- No other concurrent medication that contains bupropion hydrochloride
- No concurrent psychoactive medications
Sites / Locations
- Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center
- Swope Health Central
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Bupropion Arm
Health Education Arm
Subjects undergo smoking cessation intervention and take bupropion.
Subjects receive counseling intervention and take placebo.